Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9789 |
High Similarity |
NPD1512 |
Approved |
0.9648 |
High Similarity |
NPD1511 |
Approved |
0.9459 |
High Similarity |
NPD2801 |
Approved |
0.9007 |
High Similarity |
NPD1934 |
Approved |
0.8954 |
High Similarity |
NPD3882 |
Suspended |
0.8947 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8792 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8766 |
High Similarity |
NPD3817 |
Phase 2 |
0.8765 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8679 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8679 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8679 |
High Similarity |
NPD6166 |
Phase 2 |
0.8571 |
High Similarity |
NPD3818 |
Discontinued |
0.8571 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8571 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8562 |
High Similarity |
NPD1510 |
Phase 2 |
0.8542 |
High Similarity |
NPD943 |
Approved |
0.8528 |
High Similarity |
NPD6797 |
Phase 2 |
0.8514 |
High Similarity |
NPD1549 |
Phase 2 |
0.8476 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8408 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8405 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8354 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8354 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8313 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8311 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.8288 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8269 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8261 |
Intermediate Similarity |
NPD1247 |
Approved |
0.8242 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8235 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8228 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8199 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8187 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8187 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8182 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8176 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8146 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8138 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8133 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8113 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8084 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8069 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.805 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8039 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7988 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7987 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7964 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7962 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7952 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7949 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7925 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7919 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7919 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7914 |
Intermediate Similarity |
NPD919 |
Approved |
0.7895 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7888 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7867 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7857 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7853 |
Intermediate Similarity |
NPD3749 |
Approved |
0.784 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7831 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7764 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7751 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7712 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7711 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7692 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7687 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7667 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7643 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7628 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7625 |
Intermediate Similarity |
NPD920 |
Approved |
0.7613 |
Intermediate Similarity |
NPD2344 |
Approved |
0.761 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7603 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7597 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.758 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7578 |
Intermediate Similarity |
NPD1653 |
Approved |
0.756 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.755 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7531 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7514 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD2532 |
Approved |
0.75 |
Intermediate Similarity |
NPD2534 |
Approved |
0.75 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.75 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7484 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7471 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.747 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7467 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7436 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7436 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7421 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7415 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7407 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7405 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7389 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7372 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7368 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7365 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7333 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7318 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7297 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7297 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.729 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7273 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7257 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.725 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7248 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7248 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7247 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7244 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7241 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7222 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7222 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7208 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7208 |
Intermediate Similarity |
NPD411 |
Approved |
0.72 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7193 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7186 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7181 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7181 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7179 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7176 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7171 |
Intermediate Similarity |
NPD2798 |
Approved |
0.717 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7161 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7152 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7151 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7111 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7105 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7101 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7097 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7081 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7078 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7078 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7069 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7059 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7059 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7059 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7059 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7059 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7059 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7059 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7047 |
Intermediate Similarity |
NPD17 |
Approved |
0.7044 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7022 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7013 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.6994 |
Remote Similarity |
NPD2354 |
Approved |
0.6993 |
Remote Similarity |
NPD3267 |
Approved |
0.6993 |
Remote Similarity |
NPD3266 |
Approved |
0.6987 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6987 |
Remote Similarity |
NPD3764 |
Approved |
0.6987 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6982 |
Remote Similarity |
NPD37 |
Approved |
0.6975 |
Remote Similarity |
NPD2654 |
Approved |
0.6973 |
Remote Similarity |
NPD4360 |
Phase 2 |
0.6973 |
Remote Similarity |
NPD4363 |
Phase 3 |
0.697 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.697 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6959 |
Remote Similarity |
NPD4966 |
Approved |
0.6959 |
Remote Similarity |
NPD4965 |
Approved |
0.6959 |
Remote Similarity |
NPD4967 |
Phase 2 |
0.6954 |
Remote Similarity |
NPD5710 |
Approved |
0.6954 |
Remote Similarity |
NPD5711 |
Approved |
0.6951 |
Remote Similarity |
NPD3300 |
Phase 2 |
0.6947 |
Remote Similarity |
NPD7435 |
Discontinued |
0.6944 |
Remote Similarity |
NPD8313 |
Approved |
0.6944 |
Remote Similarity |
NPD8312 |
Approved |
0.694 |
Remote Similarity |
NPD4287 |
Approved |
0.6923 |
Remote Similarity |
NPD4625 |
Phase 3 |
0.6923 |
Remote Similarity |
NPD8150 |
Discontinued |
0.6914 |
Remote Similarity |
NPD5242 |
Approved |
0.6913 |
Remote Similarity |
NPD9545 |
Approved |
0.6901 |
Remote Similarity |
NPD2296 |
Approved |
0.6899 |
Remote Similarity |
NPD4307 |
Phase 2 |
0.6893 |
Remote Similarity |
NPD7228 |
Approved |
0.6892 |
Remote Similarity |
NPD9493 |
Approved |
0.6892 |
Remote Similarity |
NPD405 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.6871 |
Remote Similarity |
NPD1652 |
Phase 2 |
0.6863 |
Remote Similarity |
NPD4749 |
Approved |
0.6859 |
Remote Similarity |
NPD7696 |
Phase 3 |
0.6859 |
Remote Similarity |
NPD7698 |
Approved |
0.6859 |
Remote Similarity |
NPD7697 |
Approved |
0.6857 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6855 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6845 |
Remote Similarity |
NPD4361 |
Phase 2 |
0.6845 |
Remote Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.6839 |
Remote Similarity |
NPD1019 |
Discontinued |
0.6824 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6824 |
Remote Similarity |
NPD6386 |
Approved |
0.6824 |
Remote Similarity |
NPD6385 |
Approved |
0.6823
|
Remote Similarity |
NPD7871 |
Phase 2 |